Pharmaceutical products in Oman are regulated by the Ministry of Health (MOH) through the Directorate General of Pharmaceutical Affairs and Drug Control (DGPA&DC). Oman has introduced barcode based identification requirements for medicines to improve product verification and strengthen pharmaceutical supply chain monitoring.
Oman aligns with GCC pharmaceutical identification standards, which encourage the use of GS1 compliant DataMatrix barcodes on pharmaceutical packaging. These barcodes enable unique identification of medicines and support verification during distribution and dispensing.
While Oman requires standardized barcode identification for medicines, the country does not currently operate a centralized national serialization reporting platform comparable to those implemented in some other GCC markets. Traceability oversight is primarily supported through product identification standards, supply chain documentation, and regulatory inspections.